Zinca

Quick links to important sections

Zinca

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zinca

What is Zinca? Defining the Essential Mineral Supplement

Property Description
Active ingredient Zinc Sulfate (ZnSO4)
Form Oral Solution, Dispersible Tablet
Pharmacological class Mineral Supplement, Trace Element Replenishment Agent
Common use Addressing/Preventing Zinc Deficiency
Origin Synthetic (pharmaceutical salt)

Zinca is a mineral supplement that falls into the pharmacological class of trace element replenishment agents, supplying the active pharmaceutical ingredient Zinc Sulfate (ZnSO4). This compound is a highly bioavailable, synthesized salt form of the essential micronutrient zinc. Zinc Sulfate is recognized on the List of Essential Medicines, which establishes its role in correcting widespread nutritional deficiencies.

This product is primarily categorized by its function: to ensure the systemic availability of the zinc ion (Zn^2+) to correct or prevent states of zinc deficiency in the body. Unlike complex vitamin formulas, Zinca is typically designed as a single active ingredient product, ensuring focused and standardized delivery of this critical element.


Forms, Features, and General Therapeutic Purpose

Zinca is available for oral administration in patient-friendly dosage forms such as the oral solution and the dispersible tablet. The dispersible tablet is a key feature that simplifies patient intake, particularly for the pediatric population, as it dissolves quickly and ensures effective ingestion of the active compound.

The general therapeutic purpose of Zinca is to support the body’s fundamental processes that rely on adequate zinc levels. Zinc acts as an essential enzyme cofactor, which helps maintain the integrity of skin and mucosal membranes. By replenishing this essential micronutrient, Zinca serves as an adjunctive therapy that supports general well-being, enhances immune function, and promotes faster physiological recovery in scenarios where zinc levels may be compromised.

Regulatory References

  1. Zinc sulfate - Electronic Essential Medicines List

What side effects are possible with Zinca?

Possible Side Effects and Safety Information

The safety profile of Zinca (zinc acetate) is officially documented based on clinical experience and regulatory surveillance. The adverse reactions are primarily classified by system-organ class and frequency, which is consistent with the European Medicines Agency (EMA) framework.


Adverse Reaction Summary

Classification Adverse Reactions Notes
Common Gastric irritation (upset stomach), increased blood amylase, lipase, and alkaline phosphatase. Gastric irritation is often most pronounced with the first morning dose.
Uncommon Sideroblastic anemia, leukopenia (low white blood cell count). These are potential early manifestations of treatment-induced copper deficiency.

Serious Safety Considerations and Limitations

  • Copper Deficiency: Long-term use of zinc acetate is known to inhibit copper absorption, which may lead to copper deficiency. This is a clinically significant risk that can manifest as sideroblastic anemia, leukopenia, and, in rare cases, myeloneuropathy. Patients require regular hematological and biochemical monitoring to detect these changes.
  • Gastrointestinal Risk: Post-marketing surveillance has reported cases of gastric ulcers with long-term zinc acetate use, in some instances progressing to gastric ulcer perforation.
  • Overdose: Acute overdose with high doses of zinc salts has been associated with severe outcomes, including renal failure and hemorrhagic pancreatitis.

Treatment initiation must be supervised by a physician experienced in managing the underlying condition, and the dosage may be adjusted based on the patient's individual copper and hematological status.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define Zinca (Zinc Sulfate) overdose by its potential for severe toxicity and corrosive effects.

Documented Overdose Manifestations

System Official Regulatory Statements
Gastrointestinal Nausea, vomiting, diarrhea, abdominal pain, gastritis, and potential haematemesis (bloody vomiting) [Source: Regulatory SmPC, DailyMed].
Systemic/Severe Hypotension, tachycardia, dizziness, fainting, jaundice (yellow skin/eyes), pulmonary edema, and severe organ damage including acute renal tubular necrosis [Source: Regulatory SmPC, EMA EPAR, MedlinePlus].

Required Emergency Action

In all cases of suspected overdose, immediate action is required. Patients must seek medical help right away [Source: Government Guidance].

Interventions involving further irritation of the GI tract, such as induced vomiting or gastric lavage, are generally avoided due to the high risk of exacerbating the corrosive damage caused by zinc sulfate [Source: Regulatory SmPC]. Treatment is primarily supportive and may include chelating agents if dangerously high plasma zinc levels are confirmed [Source: EMA EPAR]. Patients may require hospital monitoring to assess for severe complications like renal failure.

Chronic Overdose Note

Long-term excessive intake of zinc is officially documented to carry a risk of resulting in a serious copper deficiency [Source: Regulatory SmPC].

Therapeutic Uses of Zinca

Zinca (zinc) is an essential trace element that helps ease the overall symptom burden in situations involving certain distressing symptoms.

What Zinca Treats: Main Uses and Benefits

Zinc is commonly used across conditions presenting with acute episodes where supportive symptomatic assistance is needed. This use is relevant when supportive symptom management is appropriate, for instance, during the common cold—it may assist with shortening the duration of symptoms. The mineral also supports wound healing.

The relevant clinical contexts of use include providing supportive relief for symptoms associated with the common cold, assisting with wound healing, reducing the duration of childhood diarrhea in some populations, and being considered relevant as part of symptomatic management for advanced age-related macular degeneration (AMD). This mineral helps address symptom clusters that may become disruptive.

Regarding its benefits during periods of heightened symptoms, the mineral supports patients during difficult episodes by easing distress. This essential support contributes to improved comfort during periods of heightened symptoms and assists with maintaining a sense of stability when symptoms interfere with routine activities.

Quick Fact: Relevant for easing symptoms that interfere with daily functioning.

This mineral supports patients during episodes of heightened discomfort associated with deficiency.

Regulatory References

  1. NIH Office of Dietary Supplements fact sheet

Eligibility and Restrictions for Use

Official Eligibility Profile for Zinc (Zinca)

This information is based strictly on authoritative government regulatory documents, detailing which populations are eligible to use medicinal zinc products (such as zinc sulfate or gluconate).


Absolute Exclusions (Contraindications)

Category Exclusion Condition
Allergy Known hypersensitivity to the active substance (zinc salts) or any of the product's excipients.
Comorbidity Pre-existing copper deficiency (for some high-dose formulations) due to the risk of exacerbation.

Conditional and Restricted Use

Use of zinc products requires caution and/or dose adjustment in patients with renal failure (kidney dysfunction) due to the potential for systemic zinc accumulation. Products containing specific excipients, such as aspartame or sorbitol, are subject to warnings for individuals with phenylketonuria or hereditary fructose intolerance, respectively.


Age and Life Stage Eligibility

  • Infants (0–6 months): Use is not recommended or contraindicated for specific indications (e.g., diarrhea treatment) due to difficulty in accurate dose administration.
  • Pregnancy and Lactation: Safety is not established for all products. Use during these periods is generally only considered if clearly necessary and must be conducted under medical supervision.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official regulatory interaction profile for Zinca (Zinc Sulfate) is primarily defined by pharmacokinetic interactions resulting from chelation, where the zinc ion forms complexes with other substances and significantly reduces their absorption.

Documented Interaction Patterns

The regulatory profile mandates strict attention to co-administration with several medicinal product categories:

  • Antibiotics and Antivirals: Co-administration with Quinolone or Tetracycline antibiotics, as well as certain Integrase Strand Transfer Inhibitors (e.g., Dolutegravir), leads to reduced plasma concentrations of the co-administered drug.
  • Chelating Agents: Substances like Penicillamine and Trientine may reduce the absorption of zinc, and vice-versa.
  • Other Mineral Supplements: Co-ingestion with high doses of Oral Iron or Calcium salts is officially documented to interfere with zinc absorption.

Administration Timing Constraints

To mitigate reduced exposure and maintain the efficacy of interacting medicines, government labeling requires mandatory separation intervals. For example, co-administration with Dolutegravir must be separated by at least two hours before or six hours after Zinca. Timing separation is also required for agents like Eltrombopag and Bisphosphonate Derivatives.

Population and Restriction Notes

Certain combinations are classified as formally contraindicated, such as co-administration with Baloxavir Marboxil. Furthermore, due to the use of Aspartame as an excipient in some formulations, a mandatory caution is specified for the Phenylketonuria (PKU) population.

Mechanism of Action

How Zinca Works

The action of Zinca is a mechanistic restoration, achieved by supplying the essential zinc ion ( Zn^2+), restoring the availability of Zn^2+ to its specific binding sites across hundreds of key biological systems. Its mechanism involves three core domains of action: cofactor restoration, immune pathway modulation, and fluid transport control.


Enabling Gene Regulation and Cell Repair

This domain focuses on the Zn^2+ ion acting as a cofactor for over 300 metalloenzymes and providing the structural integrity for zinc-finger transcription factors. By restoring the catalytic function of enzymes like DNA and RNA Polymerases, the mechanism supports the necessary molecular steps for accelerated cell proliferation and tissue regeneration, which contributes to the structural stabilization and regeneration processes of epithelial cell layers.


Modulating Immune Function and Antioxidant Defense

The mechanism involves Zn^2+ directly supporting the maturation and integrity of T-lymphocytes and acting as a necessary component for the antioxidant enzyme Superoxide Dismutase. This influences the proliferation and maturation processes of T-lymphocytes and enables the catalytic activity of antioxidant enzymes like Superoxide Dismutase, resulting in the neutralization of reactive oxygen species.


Localized Intestinal Fluid Modulation

A distinct mechanism occurs within the gut where the Zn^2+ ion directly acts as an inhibitor on specific basolateral potassium ( K^+) channels in the intestinal lining. This targeted blockade counteracts excessive fluid secretion, which results in the physiological modulation of water and electrolyte movement across the intestinal lumen.

Dosage and Administration Information

Administration Guidelines for Zinca

Zinca (zinc sulfate) is administered via two primary routes: oral (using tablets, solutions, or dispersible tablets) and intravenous (IV) infusion for patients receiving Total Parenteral Nutrition (TPN). All dosages are based on the content of elemental zinc.


Administration Scope Instruction (Elemental Zinc)
Dosing Regimens Standard daily IV dosage for metabolically stable adults is typically 2.5 mg to 4 mg. Oral dosing for therapeutic supplementation generally ranges up to 50 mg once daily.
Age-Group Rules Specific weight-based IV dosing applies to pediatric patients, such as 100 mug/kg/day for full-term infants and children up to 5 years, or 300 mug/kg/day for preterm neonates. For acute oral short courses, infants under 6 months receive 10 mg once daily, and children 6 months to 5 years receive 20 mg once daily.
Duration Patterns Use is defined by either a long-term daily regimen (e.g., as a TPN additive) or a short, fixed course (e.g., 10 to 14 consecutive days for acute pediatric treatment).
Timing & Preparation Oral doses may be taken with food if stomach upset occurs. The IV Injection is not for direct infusion; it must be diluted and transferred as an admixture into a larger parenteral nutrition solution prior to use.
Missed-Dose Rules If a dose is missed, it should be taken as soon as possible, but a double dose must not be taken to make up for the omission.

Connection to the overall use protocol

The established protocol defines distinct dosage forms and elemental zinc strengths that must be administered via approved oral or IV routes. These instructions govern the overall treatment plan through fixed frequency, specific dosing adjustments for age and clinical context, and mandatory preparation steps like IV dilution, thereby ensuring the medicine is used according to established standards.

Recent Clinical Evidence

Zinca: Recent Clinical Evidence

Clinical evidence on Zinca (a form of zinc supplementation) suggests a role in multiple physiological processes, primarily supporting immune function and cellular integrity. Studies show that adequate zinc status is critical for immune cells, with deficiency being associated with reduced T-cell generation and increased frequency of certain infections.

Efficacy Findings

Research has explored the use of zinc supplementation across several conditions, with varying levels of evidence observed:

  • Common Cold: Some randomized controlled trials (RCTs) suggest that administering zinc lozenges or syrup within 24 hours of symptom onset may shorten the duration of the common cold in adults. However, results across all trials have been inconsistent, and further research is ongoing to establish optimal dosing and efficacy across different populations. The use of intranasal zinc has been associated with a potential risk of loss of the sense of smell.
  • Diarrhea in Children: Clinical data indicates that zinc supplementation may help ease the duration and severity of diarrhea symptoms in children who are undernourished or have low zinc levels. This is a common public health recommendation in some developing regions where zinc deficiency is more prevalent.
  • Age-Related Macular Degeneration (AMD): Certain clinical trials have investigated zinc as part of a combination formulation, which appeared to slow the progression of intermediate or advanced AMD. Zinc is often combined with other antioxidants in research settings for this purpose.

Safety and Tolerability

Zinca is generally considered safe when taken in recommended amounts. However, high-dose or long-term use has been associated with potential adverse effects, including nausea, vomiting, abdominal pain, and diarrhea. Taking high doses of zinc over an extended period may interfere with the absorption of other essential trace minerals, such as copper, which could lead to related health issues.

Frequently Asked Questions (FAQ)

Common questions about Zinca (FAQ)

Q: What is the main ingredient in Zinca?

According to the official product information, the main active ingredient in Zinca is zinc sulfate heptahydrate, which is a form of zinc. Zinc is an essential trace element that plays a role in many body processes.

Q: What is Zinca used for?

Regulatory documents state that Zinca is used to prevent or treat zinc deficiency in individuals. It is also indicated for use as a supplement to help improve or maintain the function of the immune system.

Q: Does Zinca contain any common allergens, such as gluten or lactose?

The official product information lists the ingredients of Zinca. It is indicated that the product does not contain gluten. However, it is noted that lactose monohydrate is included as a common inactive ingredient (excipient).

Q: If I miss a dose of Zinca, what should I do?

According to the official product documentation, if a dose is missed, regulatory information suggests taking it as soon as it is remembered. However, if it is almost time for the next scheduled dose, it is generally advised to skip the missed dose and continue with the regular schedule. It is important not to take a double dose to compensate for a missed one.

Q: Can I take Zinca with food, or should I take it on an empty stomach?

Studies and official information indicate that Zinca can be taken with or immediately after food. This instruction is included because taking it with food may help to reduce the possibility of stomach upset.

How should Zinca be stored and disposed of?

The storage and disposal of Zinca (Zinc Sulfate) must adhere strictly to regulatory guidelines to maintain its stability and prevent environmental contamination.

Storage Conditions

Requirement Official Instruction
Temperature Store at controlled room temperature, typically not exceeding 30 °C (86°F).
Protection Protect from moisture and light. Keep the container tightly closed and in its original packaging.
Constraints The solid form should not be refrigerated or frozen.
Child Safety Keep out of the sight and reach of children (mandatory safety label).

Disposal

Disposal must be executed in accordance with local, regional, and national regulations. Unused or expired medication must not be flushed down the toilet or disposed of in household wastewater due to its documented toxicity to aquatic life. Return unused product to a designated drug take-back program or pharmacy when available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zinca found in:

A-Z Index: